Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label, Oral, Multiple-Dose, Six-Sequence, Three-Period Crossover Phase 1 Clinical Trial to Evaluate the Safety and Drug-Drug Interactions of "AG2203L" and "AG2203E" in Healthy Adult Participants.

NCT07797621 is registered in ClinicalTrials.gov with Ahn-Gook Pharmaceuticals Co.,Ltd as lead sponsor.

NCT NCT07797621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07797621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label, Oral, Multiple-Dose, Six-Sequence, Three-Period Crossover Phase 1 Clinical Trial to Evaluate the Safety and Drug-Drug Interactions of "AG2203L" and "AG2203E" in Healthy Adult Participants.
Lead sponsor
Ahn-Gook Pharmaceuticals Co.,Ltd
Phase
Phase 1
Overall status
Completed
Start date
March 28, 2025
Completion date
May 2, 2025
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute bronchitis